We are live on ! Find out more
KLDO

Kaleido Biosciences, Inc. Common Stock
KLDO

Delisted

KLDO was delisted on the 14th of April, 2022.

Back to rankings

3 hedge funds and large institutions have $31K invested in Kaleido Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% less funds holding

Funds holding: 63 → 3 (-60)

100% less capital invested

Capital invested by funds: $55.1M → $31K (-$55.1M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 58

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-60
Holders Change %
-95.24%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
58
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
FP
Flagship Pioneering
Massachusetts
-$32.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.5M
3
HP
Harbourvest Partners
Massachusetts
-$3.03M
4
BlackRock
BlackRock
New York
-$1.51M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
– -$19K -11,600 Closed
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
– -$17K -10,484 Closed
TYCC
28
Texas Yale Capital Corp
Florida
– -$17K -10,000 Closed
AIG
29
American International Group
New York
– -$16K -9,618 Closed
Morgan Stanley
30
Morgan Stanley
New York
– -$14K -9,554 Closed
TRCT
31
Tower Research Capital (TRC)
New York
– -$16K -9,407 Closed
JP Morgan Chase
32
JP Morgan Chase
New York
– -$15K -9,197 Closed
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
– -$15K -9,073 Closed
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
– -$13K -7,821 Closed
CAM
35
Close Asset Management
United Kingdom
– -$7.06K -7,800 -99%
Wells Fargo
36
Wells Fargo
California
– -$8K -5,183 Closed
Osaic Holdings
37
Osaic Holdings
Arizona
– -$6K -3,891 Closed
AB
38
Amalgamated Bank
New York
– -$5K -3,266 Closed
Barclays
39
Barclays
United Kingdom
– -$5K -3,146 Closed
US Bancorp
40
US Bancorp
Minnesota
– -$5K -3,000 Closed
FDCDDQ
41
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$4.83K -2,930 Closed
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
– -$3.19K -1,935 Closed
Legal & General Group
43
Legal & General Group
United Kingdom
– -$3K -1,885 Closed
Citigroup
44
Citigroup
New York
– -$2K -1,442 Closed
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
– -$2K -1,366 Closed
Simplex Trading
46
Simplex Trading
Illinois
– -$1.15K -1,268 Closed
EWM
47
Endurance Wealth Management
Rhode Island
– -$2K -1,000 Closed
AIP
48
Ameritas Investment Partners
Nebraska
– -$2K -995 Closed
LWANC
49
Laurel Wealth Advisors (North Carolina)
North Carolina
– -$1K -625 Closed
CAPTRUST Financial Advisors
50
CAPTRUST Financial Advisors
North Carolina
– -$466 -515 -80%
1
2
3

KLDO Hedge Fund Activity: Q2 2022 in Review

3 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Kaleido Biosciences, Inc. Common Stock (KLDO) for Q2 2022, worth a combined $31K — down 100% from $55.1M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of KLDO and 0 opened new positions — a net loss of 58 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Flagship Pioneering, exiting entirely with an estimated $32.3M sold.

  • 3 institutional investors held Kaleido Biosciences, Inc. Common Stock (KLDO) as of Q2 2022, down from 63 in Q1 2022.
  • Funds reported $31K of Kaleido Biosciences, Inc. Common Stock stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Kaleido Biosciences, Inc. Common Stock positions in Q2 2022 and 58 closed out, a net change of -58 holders.
  • The largest Kaleido Biosciences, Inc. Common Stock seller in Q2 2022 was Flagship Pioneering, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2022.